Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations
- Author(s)
- Claudiani, S; Chee, L; Fernando, F; Brown, L; Achandira, UM; Khan, A; Rothwell, K; Hayden, C; Koutsavlis, I; Hannah, G; Innes, A; Apperley, JF; Milojkovic, D;
- Details
- Publication Year 2024-06,Volume 99,Issue #6,Page 1172-1174
- Journal Title
- American Journal of Hematology
- Publication Type
- Research article
- Abstract
- Probability of treatment-free remission (TFR) in CML patients with additional chromosomal abnormalities (ACA) in the Philadelphia-positive clone or variant Philadelphia translocations (ACA/Var-Ph group, blue panel), in those with no cytogenetic abnormality other than the classical Philadelphia translocation (c-Ph group, green panel) and in the subgroups of CML patients with high-risk ACA (HR-ACA, yellow panel) and Var-Ph (red panel).
- Publisher
- Wiley
- Keywords
- Humans; *Translocation, Genetic; *Philadelphia Chromosome; *Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics/drug therapy; Female; Male; *Remission Induction; Adult; Middle Aged; Chromosome Aberrations; Aged; Adolescent
- Department(s)
- Clinical Haematology
- Publisher's Version
- https://doi.org/10.1002/ajh.27278
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-07-04 12:38:03
Last Modified: 2024-07-04 12:38:35